Bernstein Alan
Canadian Institute for Advanced Research, Toronto Canada.
Clin Invest Med. 2018 Nov 3;41:9-10. doi: 10.25011/cim.v41i2.31410.
After PhD studies at the University of Toronto, and postdoctoral work in London, Alan worked at the Ontario Cancer Institute and then the Samuel Lunenfeld Research Institute (eventually as Director of Research). As inaugural president of the Canadian Institutes of Health Research (CIHR; 2000-2007), he led the transformation of health research in Canada and an almost tripling of the budget for health research. He then was named executive director of the Global HIV Vaccine Enterprise (2008-2012). Since 2012, Alan has been president of CIFAR, Canada's global research institute, where he has led major initiatives to increase CIFAR's programs of research and global impact, and launched new programs to nurture the world's next generation of researchers. Author of 250 scientific and 50 op-ed and lay publications, Alan has received numerous awards and honors, including induction into the Orders of Canada and Ontario, honorary degrees, the Gairdner Wightman Award, induction into the Canadian Medical Hall of Fame and the Henry Friesen International Prize.
在多伦多大学攻读博士学位并在伦敦从事博士后工作后，艾伦曾在安大略癌症研究所工作，之后又在塞缪尔·伦嫩菲尔德研究所任职（最终担任研究所所长）。作为加拿大卫生研究院（CIHR；2000 - 2007年）的首任院长，他引领了加拿大卫生研究领域的变革，并使卫生研究预算几乎增长了两倍。随后，他被任命为全球HIV疫苗企业联盟的执行董事（2008 - 2012年）。自2012年以来，艾伦一直担任加拿大全球研究机构CIFAR的主席，在此期间，他领导了多项重大举措，以增加CIFAR的研究项目及其全球影响力，并推出了新的项目来培养全球下一代研究人员。艾伦撰写了250篇科学论文以及50篇专栏文章和通俗读物，获得了众多奖项和荣誉，包括被授予加拿大勋章和安大略勋章、荣誉学位、盖尔德纳·怀特曼奖、入选加拿大医学名人堂以及获得亨利·弗里森国际奖。
